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Lagaaij et al [3] have recently reported that graftsA prospective trial correlating clinical outcomes with
in which the endothelial cells are damaged by vascularADAMTS-13 activity levels will clarify the role of re-
rejection may incorporate host endothelium as part ofplenishing ADAMTS-13 and/or removing inhibitors in
the repair process. They speculate that host endothelialdeterming TMA response to plasma therapy.
cells may be recruited from endothelial stem cells in the
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Risk factors for late kidneyassociation with vascular
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To the Editor: We congratulate Ponticelli et al [1] forkidney transplantation an excellent paper regarding the evaluation of risk fac-
tors for late kidney allograft failure that recently ap-
peared in Kidney International. However, we would like
To the Editor: Cell migration from the host to the to suggest to the authors to see for the effect of nephron
transplanted organ results in chimerism in the organ [1]. dosing on late allograft failure. Although the authors
Chimerism may be detected after gender-mismatched have evaluated body mass index (BMI) (25 vs. 25)
organ transplantation with use of fluorescence in situ as a risk factor and found no significant effect. This may
hybridization [2]. To verify the endothelial chimerism, not have become significant as extreme BMI groups were
we studied kidney grafts with immunohistochemistry for not considered separately. Meier-Kriesche et al have
ABO blood-group antigens and in situ hybridization for observed in their study that the relative risk of graft loss
Y chromosome. death censored and uncensored was more in extremes
Four male recipients had received living kidney trans- of BMI compared to other categories. It was evident
that of the extreme groups the relative risk of chronicplants from female donors. The blood type of the recipi-
allograft nephropathy (CAN) was significantly more inents was type A in all cases, and that of donors were
high BMI group [2]. We have observed in our study andtype O in two cases and type B in two cases. Needle
it has been well reported by others that kidneys withbiopsies were performed from 2 to 5 months after kidney
insufficient nephron mass for the recipient may be dam-transplantation and diagnosed as vascular rejection. En-
aged by hyperfiltration injury resulting into proteinuriadothelial cells stained with CD34 were positive for Y
and CAN [3–5]. Thus we feel that if authors can analyzechromosomes, indicating the presence of recipient-type
nephron dosing in addition to other well studied riskmale cells. These endothelial cells were positively stained
factors in this cohort, it would be a significant contribu-for recipient-type blood group A. The patients in the
tion to the literature.
present study have shown that replacement of donor
endothelium by recipient cells does occur in vascular Navalkishor Udgiri, Randeep Kashyap, and Mukut Minz
Chandigarh, Indiarejection after kidney transplantation.
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an upturn for body mass index (BMI) 34, and only
Reply from the Authors when adjusted. Although not surprising, this finding is
new, and provision of more information on patient num-We thank Drs. Udgiri, Kashyap, and Minz for their
bers, case-mix characteristics, and statistical significancecomments and suggestions. However, the data of Meier-
between adjusted and unadjusted groups, particularly inKriesche et al referred to a retrospective analysis of
the 34 BMI category, would help the readers to better51,927 renal transplants registered in United States Re-
understand the ramifications of this finding.nal Data System (USRDS). Our data were drawn from
Figure 3 in the paper of Lowrie, Ofsthun, and Lazarusa single center experience on quite a smaller number of
[1] supports the statement that small and underweightpatients. Only one of our patients had a body mass index
patients are susceptible to underdialysis. However, it(BMI) higher than 36 kg/m2, which according to Meier-
should be noted that given the current practice of hemo-Kriesche, has the highest risk of graft failure. After 14
dialysis in the United States, it would be uncommon toyears, the allograft of this patient is still functioning with
find a small or underweight patient receiving lower dosea serum creatinine was 2.0 mg/dL. We considered an-
of dialysis; for instance, the frequency of underweightother 14 patients with BMI higher than 30 kg/m2. Their
patients with a standard prescription Kt/V of 1.2 wasgraft survival probability at 15 years was 92.8%, their
1% in a recent study [3]. When standard prescriptionmedian serum creatinine at the last visit was 1.4 mg/dL
of hemodialysis is applied, dialysis dose, as expressed as(0.9 to 2.9 mg/dL), by excluding the only patient who
Kt/V or urea reduction ratio (URR), is predictably higherreturned to dialysis.
in small and underweight patients than normal or over-On the other hand, Meier-Kriesche et al interpreted
weight patients. Thus, it is more common to see under-with caution their own data. They pointed out that it
weight patients receiving more dialysis than overweightwas difficult to ascertain whether the poor death-censored
and obese patients [3]. Despite this information, under-graft survival in obese patients was attributable to neph-
weight patients have a higher mortality, and conversely,ron underdosing or whether it was an obesity-related
despite underdialysis, overweight patients tend to havecomorbidity jeopardizing the graft, such as obesity and
a better survival [3]. The point is that once the patienthypertension. Moreover, they found that also a low BMI
receives a certain amount of dialysis, the survival is lessincreased the risk of late failure. It is difficult to advocate
dependent on dialysis dose delivered per treatment, butany role for an insufficient nephron mass in the latter
more to factors such as nutrition and comorbid condi-patients.
tions.Although the potential role of nephron underdosing
Thus, the extremely low Kt that is used by Lowrie,in chronic allograft nephropathy (CAN) is intellectually
Ofsthun, and Lazarus in underweight patients to demon-attractive and worth of further investigation, we think
strate the deleterious effect of underdialysis in such pa-that the risk of glomerular hyperfiltration caused by an
tients is outside the range obtained in regular clinicalinadequate nephron mass of the donor is overwhelmed
practice. Therefore, we are concerned that the reportedby many other more relevant risk factors.
results of the statistical analysis may be based on extrapo-
lation outside the plausible data with a few cases thatClaudio Ponticelli and Margarita Villa
Milan, Italy may exhibit undue influence on the regression. We think
